GlassScriptPhysician profile
Lisa Ann Joson
NPI 1588711543
$2,079.23
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $974 · 2020: $923 · 2021: $183.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $322.98 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $248.96 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $182.04 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $137.15 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $129.15 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $102.49 | 2019-2020 | |
| Neos Therapeutics, LP | $101.67 | 2019-2020 | |
| Allergan, INC. | $90.99 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $84.47 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $74.32 | 2019-2021 | |
| Tris Pharma INC | $65.59 | 2019-2020 | |
| Harmony Biosciences LLC | $64.71 | 2020 | |
| Vertical Pharmaceuticals, LLC | $62.66 | 2019-2020 | |
| Alkermes, INC. | $53.41 | 2019-2020 | |
| Indivior INC. | $46.02 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $42.11 | 2019 | |
| Arbor Pharmaceuticals, INC. | $40.91 | 2019 | |
| Shire North American Group INC | $39.29 | 2019 | |
| Bausch Health US, LLC | $38.95 | 2019 | |
| Lundbeck LLC | $38.23 | 2019 | |
| Supernus Pharmaceuticals, INC. | $30.79 | 2021 | |
| Currax Pharmaceuticals LLC | $28.19 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.78 | 2019 | |
| Rhodes Pharmaceuticals L.P. | $13.79 | 2019 | |
| Adlon Therapeutics L.P. | $12.58 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Joson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.